Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections
about
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaActivities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in miceImipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for ReIn vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.Mechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosis.Imipenem-cilastatin as initial therapy for febrile cancer patientsProspective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.Combination therapy for treatment of infections with gram-negative bacteria.Antibiotic combinations: should they be tested?Empiric therapy for febrile neutropenia: what are the choices?The penicillins today.Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.National Survey of Thai Infectious Disease Physicians on Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: The Role of Infection Control Awareness.Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.Development of resistance during antibiotic therapy.Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsEarly synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.Infections in cancer patients: some controversial issues.A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.Empiric antimicrobial therapy for febrile granulocytopenic cancer patients. Lessons from four EORTC trials.Imipenem/cilastatin therapy of infections in cancer patients.Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
P2860
Q24201201-36A001E0-BC6A-44F9-A483-61EAE0A42EC4Q24201767-F6946DA4-DEBA-4715-B42A-9049E4BF48C1Q24248048-979CED2F-8BEC-4CC8-8B99-DBF3D6B53FF2Q33737910-1CE101CE-EC9D-4C65-8185-BDFF1FEA11DDQ33737945-DF16C920-2BD9-4F4B-94CC-051BB484962EQ34128899-632BDEDE-1050-41D6-B56D-77624FCC8727Q35007624-13B0444E-8C9C-497F-9CA7-578B6AA1B2FAQ35124179-19B569BF-B13E-46A6-B935-A135B406BE6CQ35139159-FC420EE6-9B10-457C-891D-9BB31036AAADQ35541828-322A5741-8D4F-42A1-B32B-B75712E62E0CQ35651131-C417BBF7-85C7-4AD3-B380-21FF67A31375Q35821552-8BCBF79F-8AD0-45C0-BACF-A1A6FAAE02C8Q36156077-7BB4C59F-8101-4B72-8EAA-01E2D93F34B0Q36632795-D09123C9-F7AB-4F0F-8865-B1123B82CF5BQ36839750-815D1B9B-C8A3-4314-877F-3E331B80AE3EQ37940996-1FE2B5D9-0566-4424-A8BC-A04015599945Q38069872-20202556-008E-4777-BD2B-6C1694738C89Q38383811-20818D0F-9270-4141-ADE2-D1C33F2DFA3FQ38591480-303F5AB5-CF52-4971-B9FE-3B50B9BDFBF7Q39665988-9E267194-ADCA-43B2-B194-42A2934973FFQ39833436-00CE557E-AA1D-4068-9EE8-E77D21A22B34Q39833523-87DB1D05-7C0C-4A1E-9BD0-415C3A16FB63Q39849094-4D1E42E1-B40B-4A8C-8FCB-061550230B5EQ40739451-DB79BD2B-E9A9-4249-9441-5870A4DE727AQ40770561-C75998EA-C6A5-459D-A4CE-16B8B5EBF546Q40790815-6BF34EC8-772F-4B6D-9824-2BE8AFB47E76Q40795266-E87DE4E7-4D6B-4190-809F-C2004AC16533Q43493455-7CD8B073-6AD6-4A52-8E39-1A402643BE31
P2860
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Prospective randomized trial o ...... f serious bacterial infections
@ast
Prospective randomized trial o ...... f serious bacterial infections
@en
type
label
Prospective randomized trial o ...... f serious bacterial infections
@ast
Prospective randomized trial o ...... f serious bacterial infections
@en
prefLabel
Prospective randomized trial o ...... f serious bacterial infections
@ast
Prospective randomized trial o ...... f serious bacterial infections
@en
P2093
P2860
P356
P1476
Prospective randomized trial o ...... f serious bacterial infections
@en
P2093
Gribble MJ
Grossman L
Plenderleith LH
P2860
P304
P356
10.1128/AAC.24.3.388
P407
P577
1983-09-01T00:00:00Z